Vaibhav Upadhyay, University of Colorado Anschutz Medical Campus and Krishna Mallela, University of Colorado Anschutz Medical Campus
Existing coronavirus vaccines are not as effective against newer variants of the virus. Two vaccine experts explain how new vaccines currently in development will likely offer better protection.
Countries face the reality of co-existing with COVID-19.
Charday Penn /GettyImages
Despite the halt to the federal mask mandate for mass transit, people may still choose to protect themselves. For those who do, the type of mask and how well it fits matter.
Classical antibiotics that directly kill pathogens are prone to elicit drug-resistance. Targeting host enzymes required for pathogen survival offers can limit the emergence of resistance.
Millions of U.S. children ages 5-11 have already received at least one dose of the COVID-19 vaccine.
Keith Birmingham/MediaNews Group/Pasadena Star-News via Getty Images
Moderna will ask the FDA to allow emergency use for its vaccine in children as young as 6 months, a step many parents have been anticipating.
While many immunocompromised and high-risk patients may benefit from AstraZeneca’s Evusheld, drug distribution and access have been uneven.
AP Photo/Ted S. Warren
The latest addition to the omicron lineage has been making waves in Europe. Whether it will do the same in the U.S. depends on rates of vaccination and prior infection.
It feels like everyone around you has or is recovering from COVID. Maybe you’re fatigued and wondering if it’s an after-effect? Antibody tests could confirm it one way or another.
Pregnant people are at significantly greater risk from COVID-19 than from the vaccine.
Emilija Manevska/Moment via Getty Images
A robust body of research finds that getting vaccinated against COVID-19 during pregnancy is safe and effective – and the best way to protect both mother and child from the risks of COVID-19.
The COVID-19 pandemic has taught most people more than they ever expected to know about immunology.
Membio/iStock via Getty Images Plus
The COVID-19 pandemic has brought immunology terms that are typically relegated to textbooks into our everyday vernacular. These stories helped us make sense of the ever-evolving science.
3D printers got a lot of attention when DIYers leapt to action to address equipment shortages early in the pandemic, but some everyday items found in hardware stores played a big role, too.
COVID-19 will not be the last infectious disease event of our time. We need to prepare for the next challenge with evidence and knowledge.
(Shutterstock)
Before COVID-19, clean water, antibiotics and vaccines had made us complacent about infectious disease. Infection control can no longer be taken for granted. We must be prepared for future pandemics.
In 2020 TB case detection fell by almost 20% and mortality rose for the first time in a decade. These setbacks are directly attributable to the COVID-19 pandemic.
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand